CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION IS BOTH (1) NOT MATERIAL AND (2) THE TYPE THAT THE REGISTRANT CUSTOMARILY TREATS AS PRIVATE OR CONFIDENTIAL. SUPPLY AND...Supply and Non-Exclusive License Agreement • March 29th, 2023 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMarch 29th, 2023 Company Industry JurisdictionThis Supply and Non-Exclusive License Agreement (“Agreement”), made as of May 11, 2022 (the “Effective Date”), is by and between Regeneron Pharmaceuticals, Inc. (“Regeneron”), having a place of business at 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707 and Elicio Therapeutics, Inc. (“Sponsor”), having a place of business at 451 D Street, Suite 501, Boston, MA 02210. Regeneron and Sponsor are each referred to herein individually as “Party” and collectively “Parties.”
SUPPLY AND NON-EXCLUSIVE LICENSE AGREEMENTSupply and Non-Exclusive License Agreement • May 31st, 2022 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 31st, 2022 Company Industry JurisdictionThis Supply and Non-Exclusive License Agreement (“Agreement”), made as of February 1, 2021 (the “Effective Date”), is by and between Regeneron Pharmaceuticals, Inc. (“Regeneron”), having a place of business at 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707 and MAIA Biotechnology, Inc. operating through its wholly owned subsidiary, THIO Therapeutics, Inc. (“Sponsor”), having a place of business at 444 West Lake Street, Suite 1700, Chicago, IL 60606. Regeneron and Sponsor are each referred to herein individually as “Party” and collectively “Parties”.
SUPPLY AND NON-EXCLUSIVE LICENSE AGREEMENTSupply and Non-Exclusive License Agreement • April 11th, 2022 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 11th, 2022 Company Industry JurisdictionThis Supply and Non-Exclusive License Agreement (“Agreement”), made as of February 1, 2021 (the “Effective Date”), is by and between Regeneron Pharmaceuticals, Inc. (“Regeneron”), having a place of business at 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707 and MAIA Biotechnology, Inc. operating through its wholly owned subsidiary, THIO Therapeutics, Inc. (“Sponsor”), having a place of business at 444 West Lake Street, Suite 1700, Chicago, IL 60606. Regeneron and Sponsor are each referred to herein individually as “Party” and collectively “Parties”.
SUPPLY AND NON-EXCLUSIVE LICENSE AGREEMENTSupply and Non-Exclusive License Agreement • February 14th, 2022 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 14th, 2022 Company Industry JurisdictionThis Supply and Non-Exclusive License Agreement (“Agreement”), made as of February 1, 2021 (the “Effective Date”), is by and between Regeneron Pharmaceuticals, Inc. (“Regeneron”), having a place of business at 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707 and MAIA Biotechnology, Inc. operating through its wholly owned subsidiary, THIO Therapeutics, Inc. (“Sponsor”), having a place of business at 444 West Lake Street, Suite 1700, Chicago, IL 60606. Regeneron and Sponsor are each referred to herein individually as “Party” and collectively “Parties”.
SUPPLY AND NON-EXCLUSIVE LICENSE AGREEMENTSupply and Non-Exclusive License Agreement • August 12th, 2021 • Checkmate Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 12th, 2021 Company Industry JurisdictionThis Supply and Non-Exclusive License Agreement (“Agreement”), made as of this 6th day of May 2021 (the “Effective Date”), is by and between Regeneron Pharmaceuticals, Inc. (“Regeneron”), having a place of business at 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707 and Checkmate Pharmaceuticals. (“Sponsor”), having a place of business at 245 Main Street, 2nd Floor, Cambridge MA 02142. Regeneron and Sponsor are each referred to herein individually as “Party” and collectively “Parties”.